Advances in the medical treatment of pulmonary hypertension.

about

Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.Heme oxygenase-1/p21WAF1 mediates peroxisome proliferator-activated receptor-gamma signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells.

P2860

Q37187656-9DC83163-5242-47ED-BBD0-0C71F0C30CAC Q43159115-996A5523-C0CB-450B-B38B-0FF9AEC5D0C8

P2860

Advances in the medical treatment of pulmonary hypertension.

Item

http://www.wikidata.org/entity/Q36420236

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Advances in the medical treatment of pulmonary hypertension.

@ast

Advances in the medical treatment of pulmonary hypertension.

@en

type

Item

label

Advances in the medical treatment of pulmonary hypertension.

@ast

Advances in the medical treatment of pulmonary hypertension.

@en

prefLabel

Advances in the medical treatment of pulmonary hypertension.

@ast

Advances in the medical treatment of pulmonary hypertension.

@en

P1476

Advances in the medical treatment of pulmonary hypertension.

@en

P2093

Hans B Lehmkuhl

http://www.w3.org/2001/XMLSchema#string

P2860

The L-arginine-nitric oxide pathway

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.

Sildenafil modulates hemodynamics and pulmonary gas exchange.

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Inhaled iloprost for severe pulmonary hypertension.

Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee.

Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.

Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review.

P304

311-324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000090186

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roland Hetzer

Michael Dandel

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16534227

http://www.w3.org/2001/XMLSchema#string

Advances in the medical treatment of pulmonary hypertension.

about

P2860

P2860

Advances in the medical treatment of pulmonary hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698